Advertisement

The Search for New Bioactive Microbial Metabolites

  • Giancarlo Lancini
  • Rolando Lorenzetti

Abstract

After the discovery of penicillin, systematic programs to search for new antibiotics were initiated. These resulted, in a short time, in the discovery of thousands of active molecules and, most importantly, of a number of clinically useful agents. The basic concepts of these programs, usually termed screening programs, were established by Waksman at Rutgers State University in the early 1940s. They are still valid today and are applied in many academic and industrial research laboratories all over the world.

Keywords

Fermentation Broth Newcastle Disease Virus Selective Isolation Microbial Metabolite Prophage Induction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

General

  1. Bérdy, J., 1985, Screening, classification and identification of microbial products, in Discovery and Isolation of Microbial Products ( M. S. Verral, ed.), pp. 9–31, Ellis Horwood, Chichester.Google Scholar
  2. Bérdy, J., Aszalos, A., Bostian, M., and McNitt, K. L., 1980–1982, Handbook ofAntibiotic Compounds,Vols. I-X, CRC Press, Boca Raton, Fla.Google Scholar
  3. Betina, V., 1983, The Chemistry and Biology of Antibiotics, pp. 59–101, Elsevier, Amsterdam.Google Scholar
  4. Box, S. J., 1985, Approaches to the isolation of an unidentified microbial product, in Discovery and Isolation of Microbial Products ( M. S. Verrai, ed.), pp. 32–51, Ellis Horwood, Chichester.Google Scholar
  5. Bu’Lock, J. D., Nisbet, L. J., and Winstanley, D. J., (eds.), 1982, Bioactive Microbial Products: Search and Discovery, Academic Press, New York.Google Scholar
  6. Elander, R. P., 1987, Microbial screening, selection and strain improvement, in Basic Biotechnology ( J. Bu’Lock and B. Kristiansen, eds.), pp. 217–251, Academic Press, New York.Google Scholar
  7. Gootz, J. D., 1990, Discovery and development of new antimicrobial agents, Clin. Microbiol. Rev. 3: 13.PubMedGoogle Scholar
  8. Imada, A., and Hotta, K., 1992, Hystorical perspectives of approaches to antibiotics discovery, in Emerging Targets in Antibacterial and Antifungal Chemotherapy ( J. A. Sutcliffe and N. H. Georgopapadaku, eds.), pp. 1–23, Chapman and Hall, London.CrossRefGoogle Scholar
  9. Iwai, Y., and Ömura, S., 1982, Culture conditions for screening of new antibiotics, J. Antibiot. 35: 123.PubMedCrossRefGoogle Scholar

Strain Isolation

  1. Cross, T., 1982, Actinomycetes: A continuing source of new metabolites, Dey. Ind. Microbiol. 23: 1.Google Scholar
  2. Dreyfuss, M. M., 1992, Ecology, microbial diversity and chemical creativity, in New Drugs from Natural Sources ( J. D. Coombs, ed.), pp. 59–62, IBC Technical Services, London.Google Scholar
  3. Frankland, J. C., Dighton, J., and Boddy, L., 1990, Methods for studying fungi in soil and forest litter, Methods Microbiol. 22: 343.CrossRefGoogle Scholar
  4. Hunter-Cevera, J. C., Fonda, M. E., and Belt, A., 1986, Isolation of cultures, in Manual of Industrial Microbiology and Biotechnology ( A. L. Demain and N. A. Solomon, eds.), pp. 3–23, American Society for Microbiology, Washington, D.C.Google Scholar
  5. Li, G. P., 1989, Isolation of actinomycetes for antibiotic screening, Chin. J. Antibiot. 14: 452.Google Scholar
  6. Nisbet, L. J., 1992, Natural solutions for the drug industry. An overview, in New Drugs from Natural Sources ( D. Coombes, ed.), pp. 185–190, IBC Technical Services, London.Google Scholar
  7. Nolan, R. D., and Cross, T., 1988, Isolation and screening of actinomycetes, in Actinomycetes in Biotechnology ( M. Goodfellow, S. T. Williams, and M. Mordarski, eds.), pp. 1–32, Academic Press, New York.CrossRefGoogle Scholar
  8. O’Donnell, K., and Peterson, S. W., 1992, Isolation, preservation and taxonomy, in Biotechnology of Filamentous Fungi ( D. B. Finkelstein and C. Ball, eds.), pp. 739, Butterworths/Heinemann, London.Google Scholar
  9. Reichenbach, M., and Höfle, G., 1989, The gliding bacteria: A treasury of secondary metabolites, Prog. Ind. Microbiol. 27: 79.Google Scholar
  10. Wellington, E. M. H., and Cross, T., 1983, Taxonomy of antibiotic producing actinomycetes and new approaches for their selective isolation, Prog. Ind. Microbiol. 17: 1983.Google Scholar
  11. Wells, J. S., Hunter, J. C., Astle, G. L., Sherwood, J. C., Ricca, C. M., Trejo, W. H., Bonner, D. P., and Sykes, R. B., 1982, Distribution of ß-lactam and ß-lactone producing bacteria in nature, J. Antibiot. 35: 814.PubMedCrossRefGoogle Scholar

Innovative Assays

  1. Bérdy, J., 1989, The discovery of new bioactive microbial metabolites: Screening and identification, Prog. Ind. Microbiol. 27: 3.Google Scholar
  2. Gadebush, H. H., Stapley, E. O., and Zimmerman, S. B., 1992, The discovery of cell wall active antibacterial antibiotics, Crit. Rev. Biotechnol. 12: 225.CrossRefGoogle Scholar
  3. Harris, T. J. R., Hayes, M. V., and Hobden, A. N., 1992, Molecular genetics in natural product screen design, in New Drugs from Natural Sources ( J. D. Coombes, ed.), pp. 3–12, IBC Technical Services, London.Google Scholar
  4. Hertzberg, R. P., Johnson, R. K., Caranfa, M. J., Myers, C. C., Mackenzie, L., Breen, A., Tomaszek, T. A., Meek, T. D., Debouck, C., Mai, S. H., Culp, J. S., and Francis, T. A., 1992, Mechanism based strategies for the discovery of natural product in-hibitors of HIV, in New Drugs from Natural Sources ( J. D. Coombes, ed.), pp. 4658, IBC Technical Services, London.Google Scholar
  5. Monaghan, R. L., and Tkacz, J. S., 1990, Bioactive microbial products: Focus upon mechanism of action, Annu. Rev. Microbiol. 44: 271.PubMedCrossRefGoogle Scholar
  6. Nisbet, L. J., and Westley, J. W., 1986, Developments in microbial products screening, Annu. Rep. Med. Chem. 21: 148.Google Scholar
  7. Ömura, S., 1986, Philosophy of new drug discovery, Microbiol. Rev. 50: 259.PubMedGoogle Scholar
  8. Ryley, J. F., and Barret-Bee, K., 1992, Screening for antifungal activity, in Emerging Targets in Antibacterial and Antifungal Chemotherapy ( J. A. Sutcliffe and N. H. Georgopapadaku, eds.), pp. 546–567, Chapman and Hall, London.CrossRefGoogle Scholar
  9. Schindler, P. W., 1992, The design and operation of enzyme inhibitor screens, in New Drugs from Natural Sources ( J. D. Coombes, ed.), pp. 20–35, IBC Technical Services, London.Google Scholar
  10. Selitrennikoff, C. P., 1992, Screening for antifungal drugs, in Biotechnology of Filamentous Fungi ( D. B. Finkelstein and C. Ball, eds.), pp. 189–217, Butterworths/Heinemann, London.Google Scholar
  11. White, R. J., and Maiese, W. M., 1983, Detection of microbial metabolites with antitumor activity, Frog. Ind. Microbiol. 17: 167.Google Scholar
  12. White, R. J., Maiese, W. M., and Greenstein, M., 1986, Screening of new products from microorganisms, in Manual of Industrial Microbiology and Biotechnology ( A. L. Demain and N. A. Solomon, eds.), pp. 24–31, American Society for Microbiology, Washington D.C.Google Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Giancarlo Lancini
    • 1
  • Rolando Lorenzetti
    • 1
  1. 1.MMDRI-Lepetit Research CenterGerenzano (Varese)Italy

Personalised recommendations